Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorThorne, Eleanor
dc.contributor.authorOing, Christoph
dc.contributor.authorElez Fernandez, Mª Elena
dc.contributor.authorLim, Kok Haw Jonathan
dc.contributor.authorPunie, Kevin
dc.contributor.authorMurali, Krithika
dc.contributor.authorKamposioras, Konstantnos
dc.date.accessioned2023-01-25T08:01:43Z
dc.date.available2023-01-25T08:01:43Z
dc.date.issued2022-02
dc.identifier.citationLim KHJ, Murali K, Thorne E, Punie K, Kamposioras K, Oing C, et al. The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series. ESMO Open. 2022 Feb;7(1):100374.
dc.identifier.issn2059-7029
dc.identifier.urihttps://hdl.handle.net/11351/8912
dc.descriptionCOVID-19; Oncology professionals; Resilience
dc.description.abstractBackground COVID-19 has had a significant impact on the well-being and job performance of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration set out to investigate and monitor well-being since COVID-19 in relation to work, lifestyle and support factors in oncology professionals 1 year on since the start of the pandemic. Methods An online, anonymous survey was conducted in February/March 2021 (Survey III). Key outcome variables included risk of poor well-being or distress (expanded Well-Being Index), feeling burnout (single item from expanded Well-Being Index), and job performance since COVID-19. Longitudinal analysis of responses to the series of three surveys since COVID-19 was carried out, and responses to job demands and resources questions were interrogated. SPSS V.26.0/V.27.0 and GraphPad Prism V9.0 were used for statistical analyses. Results Responses from 1269 participants from 104 countries were analysed in Survey III: 55% (n = 699/1269) female, 54% (n = 686/1269) >40 years, and 69% (n = 852/1230) of white ethnicity. There continues to be an increased risk of poor well-being or distress (n = 464/1169, 40%) and feeling burnout (n = 660/1169, 57%) compared with Survey I (25% and 38% respectively, P < 0.0001), despite improved job performance. Compared with the initial period of the pandemic, more participants report feeling overwhelmed with workload (45% versus 29%, P < 0.0001). There remain concerns about the negative impact of the pandemic on career development/training (43%), job security (37%). and international fellowship opportunities (76%). Alarmingly, 25% (n = 266/1086) are considering changing their future career with 38% (n = 100/266) contemplating leaving the profession. Conclusion Oncology professionals continue to face increased job demands. There is now significant concern regarding potential attrition in the oncology workforce. National and international stakeholders must act immediately and work closely with oncology professionals to draw up future-proof recovery plans.
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesESMO Open;7(1)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectOncologia
dc.subjectSíndrome d'esgotament professional
dc.subjectCOVID-19 (Malaltia)
dc.subject.meshCoronavirus Infections
dc.subject.meshBurnout, Professional
dc.subject.meshMedical Oncology
dc.titleThe impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.esmoop.2021.100374
dc.subject.decsinfecciones por Coronavirus
dc.subject.decsdesgaste profesional
dc.subject.decsoncología médica
dc.relation.publishversionhttps://doi.org/10.1016/j.esmoop.2021.100374
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Lim KHJ] Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester. Department of Immunology and Inflammation, Imperial College London, London. Immunobiology Laboratory, The Francis Crick Institute, London, UK. [Murali K] Victorian Clinical Genetics Services & Murdoch Children’s Research Institute, The Royal Children’s Hospital, Melbourne, Australia. [Thorne E] Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK. [Punie K] Department of General Medical Oncology and Multidisciplinary Breast Center, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. [Kamposioras K] Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester. [Oing C] Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, Mildred Scheel Cancer Career Centre HaTriCs4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. [Élez E] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.identifier.pmid35007996
dc.identifier.wos000819873600037
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record